VectorXcellerator Programme: Fully funded feasibility studies to support early-stage cell and gene therapy programmes

Webinar: Optimising viral vector manufacturing with CDMO expertise and innovation

News: OXB honoured at 2025 CDMO Leadership Awards Europe in ‘Cell & Gene Therapy’ category

Advanced Nuclease Applications in Lentiviral Vector Bioprocessing for Superior Downstream Recovery and Vector Product Quality

October 23, 2024